Bill Information

House Bill 1959
2021-2022 Regular Session
An Act providing for research and clinical studies of psilocybin, for duties of Department of Health, for duties of institutional review boards, for duties of authorized psilocybin manufacturers, for duties of approved investigators and for reports.
Co-Sponsorship Memo
Prime Sponsor
Photo of Representative Representative Tracy Pennycuick
Representative Tracy Pennycuick
R House District 147
Co-Sponsors
Photo of Representative Rep. Jennifer O'Mara
Rep. Jennifer O'Mara
D House District 165
Photo of Representative Rep. MaryLouise Isaacson
Rep. MaryLouise Isaacson
D House District 175
Photo of Representative Rep. Tina Davis
Rep. Tina Davis
D House District 141
Photo of Representative Rep. Michael Schlossberg
Rep. Michael Schlossberg
D House District 132
Photo of Representative Rep. Tim Hennessey
Rep. Tim Hennessey
R House District 26
Photo of Representative Rep. Carrie Lewis DelRosso
Rep. Carrie Lewis DelRosso
R House District 33
Photo of Representative Rep. Nancy Guenst
Rep. Nancy Guenst
D House District 152
Photo of Representative Rep. F. Todd Polinchock
Rep. F. Todd Polinchock
R House District 144
Photo of Representative Rep. Matthew Dowling
Rep. Matthew Dowling
R House District 51
Photo of Representative Rep. Joe Hamm
Rep. Joe Hamm
R House District 84
Photo of Representative Rep. Benjamin Sanchez
Rep. Benjamin Sanchez
D House District 153
Photo of Representative Rep. Christina Sappey
Rep. Christina Sappey
D House District 158
Photo of Representative Rep. Brian Sims
Rep. Brian Sims
D House District 182
Photo of Representative Rep. Timothy J. O'Neal
Rep. Timothy J. O'Neal
R House District 48
Photo of Representative Rep. Melissa Shusterman
Rep. Melissa Shusterman
D House District 157
Photo of Representative Rep. Karen Boback
Rep. Karen Boback
R House District 117
Photo of Representative Rep. Napoleon J. Nelson
Rep. Napoleon J. Nelson
D House District 154
Photo of Representative Rep. Aaron Bernstine
Rep. Aaron Bernstine
R House District 10
Photo of Representative Rep. Eric Nelson
Rep. Eric Nelson
R House District 57
Photo of Representative Rep. Jeanne McNeill
Rep. Jeanne McNeill
D House District 133
Photo of Representative Rep. Mary Jo Daley
Rep. Mary Jo Daley
D House District 148
Photo of Representative Rep. Christopher Quinn
Rep. Christopher Quinn
R House District 168
Photo of Representative Rep. Greg Rothman
Rep. Greg Rothman
R House District 87
Photo of Representative Rep. P. Sturla
Rep. P. Sturla
D House District 96
Bill Status & History
Last Action: Referred to Health, Oct. 12, 2021 House
H
S
2260 Referred to Health, Oct. 12, 2021
Printers Numbers
Oct 12, 2021
PN 2260
Votes
There are no votes available.
Committee Meetings
Voting meeting on HB 1005, HB 1644, HB 1959, HB 2013, HB 2033, HB2077 and any other business that may come before the committee.
Voting meeting on HB 1005, HB 1644, HB 1959, HB 2013, HB 2033, HB2077 and any other business that may come before the committee.
Statute References
There are no statute references for this bill.
House Bill 1959
2021-2022 Regular Session
Sponsors
PENNYCUICK, O'MARA, ISAACSON, T. DAVIS, SCHLOSSBERG, HENNESSEY, LEWIS DELROSSO, GUENST, POLINCHOCK, DOWLING, HAMM, SANCHEZ, SAPPEY, SIMS, O'NEAL, SHUSTERMAN, BOBACK, N. NELSON, BERNSTINE, E. NELSON, McNEILL, DALEY, QUINN, ROTHMAN, STURLA

Short Title
An Act providing for research and clinical studies of psilocybin, for duties of Department of Health, for duties of institutional review boards, for duties of authorized psilocybin manufacturers, for duties of approved investigators and for reports.

Memo Subject
REVISED - Public Health Benefits of Psilocybin Act

Actions
2260 Referred to HEALTH, Oct. 12, 2021

Generated 04/21/2025 06:04 PM